NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024
Awarded by NHS England · to Bayer Plc · 2024-07-25T00:00:00+01:00 · £416,830,570
Description
roject title: CM/PHS/24/5707 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
- Supplier
- Bayer Plc
- Buyer
- NHS England
- Value
- £416,830,570
- Category (CPV)
- Pharmaceutical products
- Award date
- 2024-07-25T00:00:00+01:00
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.